<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02734719</url>
  </required_header>
  <id_info>
    <org_study_id>LK-2</org_study_id>
    <nct_id>NCT02734719</nct_id>
  </id_info>
  <brief_title>Increasing Bone Density by Application of Surface Electrical Stimulation</brief_title>
  <official_title>Increasing Bone Density by Application of Surface Electrical Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Belgrade</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Belgrade</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bonestim system for osteoporosis treatment uses surface electrical stimulation of&#xD;
      neuromuscular and skeletal tissue by multipad stimulation electrodes for inducing&#xD;
      contractions of the spinal column muscles. The primary aim of this clinical study is to&#xD;
      determine if the Bonestim therapy can improve bone density. A secondary aim is to determine&#xD;
      whether the applied treatment increases postural stability and facilitation of daily life&#xD;
      activities.&#xD;
&#xD;
      Inducing of contractions of the spinal column muscles in this manner could be new treatment&#xD;
      options for the patients with reduced mobility and the patients with serious&#xD;
      contraindications for drugs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Device is not available.&#xD;
  </why_stopped>
  <start_date type="Anticipated">March 2022</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>density of bone measured by central Dxa measurement</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>sagittal flexibility measured by Schober measurement</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>daily activities measured by Oswestry disability index</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Electrical Stimulation</condition>
  <condition>Posture</condition>
  <arm_group>
    <arm_group_label>Group treated with Bonestim</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will be treated with the electrical stimulation device Bonestim.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bonestim</intervention_name>
    <description>Bonestim is the multipad electrical stimulation device.</description>
    <arm_group_label>Group treated with Bonestim</arm_group_label>
    <other_name>multipad electrical stimulation of trunk muscles</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  T score at least 1,5 (ideal 2,-2,5)&#xD;
&#xD;
          -  Stable bone turn over (lab.analyses.)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  fracture,pace maker, malignancy and gastrointestinal problems&#xD;
&#xD;
          -  chronic corticosteroid therapy&#xD;
&#xD;
          -  spinal surgery in previous year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinic for rehabilitation dr Miroslav Zotovic Faculty of Medicine University of Belgrade</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>April 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Belgrade</investigator_affiliation>
    <investigator_full_name>Konstantinovic Ljubica</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

